Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren’s syndrome: a 6-year retrospective study

ObjectivesNephritis is a life-threatening complication of primary Sjögren’s syndrome (pSS), with membranous nephropathy (MN) being prevalent. Renal biopsy is the gold standard for MN diagnosis, but it is invasive and cannot be repeatedly performed. This study aimed to develop a nomogram for the pred...

Full description

Bibliographic Details
Main Authors: Lihui Guo, Shan Zhao, Xudong Liu
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1320880/full
_version_ 1797226582986719232
author Lihui Guo
Shan Zhao
Xudong Liu
author_facet Lihui Guo
Shan Zhao
Xudong Liu
author_sort Lihui Guo
collection DOAJ
description ObjectivesNephritis is a life-threatening complication of primary Sjögren’s syndrome (pSS), with membranous nephropathy (MN) being prevalent. Renal biopsy is the gold standard for MN diagnosis, but it is invasive and cannot be repeatedly performed. This study aimed to develop a nomogram for the prediction of MN in patients with pSS.MethodsThis retrospective study included patients with pSS admitted to the Rheumatology and Immunology Department of the First Affiliated Hospital of China Medical University between January 2015 and January 2021. A nomogram was developed using multivariable logistic regression analysis and evaluated using receiver operating characteristic (ROC) curve analysis. Bootstrap resampling analysis (1,000 times) was performed to evaluate the nomogram for discrimination and the calibration curve for consistency.ResultsA total of 237 patients with pSS [aged 53.00 (44.00, 61.00) years] were included, with 35 pSS–MN patients. Based on clinical practice and multivariable logistic regression analysis, seven variables associated with pSS–MN were selected, including white blood cells, creatine, complement 3, rheumatoid factor, antinuclear antibodies, anti-SSA antibody, and interstitial lung disease. The area under the ROC curve was 0.860 (95% confidence interval: 0.796–0.919), indicating good predictive power. In addition, the nomogram exhibited excellent performance, as demonstrated by the calibration curve and decision curve analysis.ConclusionThis study developed a risk prediction nomogram for MN in patients with pSS, with high predictive power. It may be used to improve the management of patients with pSS.
first_indexed 2024-04-24T14:27:12Z
format Article
id doaj.art-bcc6a9b1e38043048b538876138f3b16
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-04-24T14:27:12Z
publishDate 2024-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-bcc6a9b1e38043048b538876138f3b162024-04-03T04:41:23ZengFrontiers Media S.A.Frontiers in Immunology1664-32242024-04-011510.3389/fimmu.2024.13208801320880Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren’s syndrome: a 6-year retrospective studyLihui GuoShan ZhaoXudong LiuObjectivesNephritis is a life-threatening complication of primary Sjögren’s syndrome (pSS), with membranous nephropathy (MN) being prevalent. Renal biopsy is the gold standard for MN diagnosis, but it is invasive and cannot be repeatedly performed. This study aimed to develop a nomogram for the prediction of MN in patients with pSS.MethodsThis retrospective study included patients with pSS admitted to the Rheumatology and Immunology Department of the First Affiliated Hospital of China Medical University between January 2015 and January 2021. A nomogram was developed using multivariable logistic regression analysis and evaluated using receiver operating characteristic (ROC) curve analysis. Bootstrap resampling analysis (1,000 times) was performed to evaluate the nomogram for discrimination and the calibration curve for consistency.ResultsA total of 237 patients with pSS [aged 53.00 (44.00, 61.00) years] were included, with 35 pSS–MN patients. Based on clinical practice and multivariable logistic regression analysis, seven variables associated with pSS–MN were selected, including white blood cells, creatine, complement 3, rheumatoid factor, antinuclear antibodies, anti-SSA antibody, and interstitial lung disease. The area under the ROC curve was 0.860 (95% confidence interval: 0.796–0.919), indicating good predictive power. In addition, the nomogram exhibited excellent performance, as demonstrated by the calibration curve and decision curve analysis.ConclusionThis study developed a risk prediction nomogram for MN in patients with pSS, with high predictive power. It may be used to improve the management of patients with pSS.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1320880/fullprimary Sjögren’s syndromemembranous nephropathynomogramretrospective studyprognostic factorrheumatoid factor
spellingShingle Lihui Guo
Shan Zhao
Xudong Liu
Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren’s syndrome: a 6-year retrospective study
Frontiers in Immunology
primary Sjögren’s syndrome
membranous nephropathy
nomogram
retrospective study
prognostic factor
rheumatoid factor
title Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren’s syndrome: a 6-year retrospective study
title_full Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren’s syndrome: a 6-year retrospective study
title_fullStr Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren’s syndrome: a 6-year retrospective study
title_full_unstemmed Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren’s syndrome: a 6-year retrospective study
title_short Development of a nomogram for membranous nephropathy prediction in patients with primary Sjögren’s syndrome: a 6-year retrospective study
title_sort development of a nomogram for membranous nephropathy prediction in patients with primary sjogren s syndrome a 6 year retrospective study
topic primary Sjögren’s syndrome
membranous nephropathy
nomogram
retrospective study
prognostic factor
rheumatoid factor
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1320880/full
work_keys_str_mv AT lihuiguo developmentofanomogramformembranousnephropathypredictioninpatientswithprimarysjogrenssyndromea6yearretrospectivestudy
AT shanzhao developmentofanomogramformembranousnephropathypredictioninpatientswithprimarysjogrenssyndromea6yearretrospectivestudy
AT xudongliu developmentofanomogramformembranousnephropathypredictioninpatientswithprimarysjogrenssyndromea6yearretrospectivestudy